Search all trials

Find therapies in clinical trials near you – page 14

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Non-small cell lung cancer

Not recruiting

Registered drug

Study on the Safety and Effectiveness of Fianlimab, Cemiplimab, and Chemotherapy in Adults with Resectable Non-Small Cell Lung Cancer

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Renal cell carcinoma

Not recruiting

Registered drug

Study of Nivolumab and Ipilimumab for Patients with Advanced Kidney Cancer and Intermediate or Poor Risk Factors

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Primary progressive multiple sclerosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Registered drug

France

Participants:18–64 years
Substances:Ocrelizumab

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

Registered drug

Study on Atezolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer with Positive ctDNA After Surgery

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Multiple sclerosis+1

Not recruiting

Registered drug

Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Registered drug

France

Participants:18–64 years
Substances:Methylprednisolone

Contact Research Centre

Non-small cell lung cancer stage III+5

Not recruiting

Registered drug

Study Comparing Ociperlimab and Tislelizumab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Ociperlimab

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drug

Study Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Amyotrophic lateral sclerosis

Not recruiting

Registered drug

Study on the Effects of NX210c and Glucose in Adults with Amyotrophic Lateral Sclerosis (ALS)

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Glucose

Contact Research Centre

Ovarian cancer stage IV+1

Not recruiting

Registered drug

Study of Niraparib and Dostarlimab Combined with Platinum Therapy for Newly Diagnosed Stage III or IV Non-mucinous Epithelial Ovarian Cancer

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Relapsing multiple sclerosis

Not recruiting

Registered drug

Study of LY3541860 and Meglumine Gadoterate for Adults with Relapsing Multiple Sclerosis

Registered drug

France

Participants:18–64 years
Substances:Ly3541860

Contact Research Centre

Colitis ulcerative+1

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Subcutaneous Infliximab for Patients with Active Crohn's Disease or Ulcerative Colitis

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Infliximab

Contact Research Centre

Ischaemic stroke

Not recruiting

Registered drug

Study on Glenzocimab for Patients with Large Ischemic Stroke Eligible for Endovascular Therapy

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Gadobutrol

Contact Research Centre

Find therapies in clinical trials near you – page 14

193 trials match your criteria

Non-small cell lung cancer

Study on the Safety and Effectiveness of Fianlimab, Cemiplimab, and Chemotherapy in Adults with Resectable Non-Small Cell Lung Cancer

Renal cell carcinoma

Study of Nivolumab and Ipilimumab for Patients with Advanced Kidney Cancer and Intermediate or Poor Risk Factors

Primary progressive multiple sclerosis

Study on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Bladder transitional cell carcinoma

Study on Atezolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer with Positive ctDNA After Surgery

Multiple sclerosis+1

Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Non-small cell lung cancer stage III+5

Study Comparing Ociperlimab and Tislelizumab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Hormone receptor positive HER2 negative breast cancer

Study Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Amyotrophic lateral sclerosis

Study on the Effects of NX210c and Glucose in Adults with Amyotrophic Lateral Sclerosis (ALS)

Ovarian cancer stage IV+1

Study of Niraparib and Dostarlimab Combined with Platinum Therapy for Newly Diagnosed Stage III or IV Non-mucinous Epithelial Ovarian Cancer

Relapsing multiple sclerosis

Study of LY3541860 and Meglumine Gadoterate for Adults with Relapsing Multiple Sclerosis

Colitis ulcerative+1

Study on the Effectiveness and Safety of Subcutaneous Infliximab for Patients with Active Crohn's Disease or Ulcerative Colitis

Ischaemic stroke

Study on Glenzocimab for Patients with Large Ischemic Stroke Eligible for Endovascular Therapy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.